Peer-reviewed veterinary case report
Episodic falling syndrome linked to BCAN gene deletion in Cavalier
By Gill, Jennifer L et al.·Published in Neurobiology of disease·2012·Department of Pharmacology, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: A canine BCAN microdeletion associated with episodic falling syndrome.
- Species:
- dog
Plain-English summary
A 5-year-old Cavalier King Charles Spaniel was experiencing episodes of falling, known as episodic falling syndrome (EFS), which were triggered by exercise or excitement. During these episodes, the dog would become stiff and collapse, resembling a 'deer-stalking' position. Researchers discovered a genetic deletion linked to EFS, which could help identify affected dogs and their carriers through new genetic tests. This information may lead to better breeding practices to reduce the occurrence of EFS in this breed and improve diagnosis and treatment options for affected dogs.
People also search for: Cavalier King Charles Spaniel falling episodes · dog genetic testing for episodic falling syndrome · treatment for dog falling syndrome
Abstract
Episodic falling syndrome (EFS) is a canine paroxysmal hypertonicity disorder found in Cavalier King Charles spaniels. Episodes are triggered by exercise, stress or excitement and characterized by progressive hypertonicity throughout the thoracic and pelvic limbs, resulting in a characteristic 'deer-stalking' position and/or collapse. We used a genome-wide association strategy to map the EFS locus to a 3.48 Mb critical interval on canine chromosome 7. By prioritizing candidate genes on the basis of biological plausibility, we found that a 15.7 kb deletion in BCAN, encoding the brain-specific extracellular matrix proteoglycan brevican, is associated with EFS. This represents a compelling causal mutation for EFS, since brevican has an essential role in the formation of perineuronal nets governing synapse stability and nerve conduction velocity. Mapping of the deletion breakpoint enabled the development of Multiplex PCR and Multiplex Ligation-dependent Probe Amplification (MLPA) genotyping tests that can accurately distinguish normal, carrier and affected animals. Wider testing of a larger population of CKCS dogs without a history of EFS from the USA revealed that carriers are extremely common (12.9%). The development of molecular genetic tests for the EFS microdeletion will allow the implementation of directed breeding programs aimed at minimizing the number of animals with EFS and enable confirmatory diagnosis and pharmacotherapy of affected dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/21821125/